# Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion

> **NCT00370266** · PHASE2 · COMPLETED · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Branch Retinal Vein Occlusion

## Interventions

- **DRUG:** Triamcinolone

## Key facts

- **NCT ID:** NCT00370266
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2007-10
- **Final completion:** 2007-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00370266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00370266, "Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00370266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*